Lupus organ damage: What is damaged in Asian patients?

Lupus

Volumn 19, Issue 12, 2010, Pages 1436-1441

  Kuan, W P ^a   Li, E K ^b   Tam, L S ^b  

^a Selayang Hospital   (Malaysia)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Asia; damage; SDI; systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; STEROID;

AGE; ASIAN; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; ETHNICITY; GENETIC POLYMORPHISM; HEART INFARCTION; HUMAN; HYPOGONADISM; KIDNEY INJURY; ORGAN INJURY; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; RACE DIFFERENCE; REVIEW; RISK FACTOR; SKIN DEFECT; SOCIOECONOMICS; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ASIA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE ORGAN FAILURE; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 78649752317     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310370050     Document Type: Review

References (47)

1. Gladman DD, Urowitz MB Prognosis, mortality, and morbidity in systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds), Dubois' lupus erythematosus, 6 th ed. Philadelphia: Lippincott Williams & Wilkins ; 2002. p. 1255-1273.
2. Trager J., Ward MM Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol 2001 ; 13: 345-351.
3. Pistiner M., Wallace DJ, Nessim S., Metzger AL, Klinenberg JR Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991 ; 21: 55-64.
4. McLaughlin J., Gladman DD, Urowitz MB, Bombardier C., Farewell VT, Cole E. Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results. Arthritis Rheum 1991 ; 34: 1268-1273.
5. Gladman DD Prognosis of systemic lupus erythematosus and factors that affect it. Curr Opin Rheumatol 1992 ; 4: 681-687.
6. Gladman D., Ginzler E., Goldsmith C., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996 ; 39: 363-369.
7. Stoll T., Seifeit B., Isenberg DA SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996 ; 35: 248-254.
8. Stoll T., Stucki G., Malik J., Pyke S., Isenberg DA Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus. J Rheumatol 1997 ; 24: 309-313.
9. Hanly JG Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross-sectional study. Lupus 1997 ; 6: 243-247.
10. Karlson EW, Daltroy LH, Lew RA, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997 ; 40: 47-56.
11. Zonana-Nacach A., Camargo-Coronel A., Yanez P., et al. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration. Lupus 1998 ; 7: 119-123.
12. Rahman P., Gladman DD, Urowitz MB, Hallet D., Tam LS Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 2001 ; 10: 93-96.
13. Alarcon GS, McGwin G., Bastian HM Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort. Arthritis Rheum 2001 ; 45: 191-202.
14. Stoll T., Sutcliffe N., Klaghofer R., Isenberg DA Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage? A prospective study. Ann Rheum Dis 2000 ; 59: 832-835.
15. Tam LS, Wong A., Mok VC, et al. The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus. J Rheumatol 2008 ; 35: 1038-1045.
16. Alarcon GS, Roseman JM, McGwin Jr G., et al. Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage. Rheumatology 2004 ; 43: 202-205.
17. Alarcon GS, McGwin Jr G., Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001 ; 44: 2797-2806.
18. Toloza SM, Roseman JM, Alarcon GS, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXII. Predictors of time to the occurrence of initial damage. Arthritis Rheum 2004 ; 50: 3177-3186.
19. Stoll T., Sutcliffe N., Mach J., Klaghofer R., Isenberg DA Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus - a 5-yr prospective study. Rheumatology 2004 ; 43: 1039-1044.
20. Zonana-Nacach A., Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 2000 ; 43: 1801-1808.
21. Gladman DD, Urowitz MB, Rahman P., Ibañez D., Tam LS Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 2003 ; 30: 1955-1959.
22. Samanta A., Feehally J., Roy S., Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991 ; 50: 490-492.
23. Kaslow RA High rate of death caused by systemic lupus erythematosus among US residents of Asian descent. Arthritis Rheum 1982 ; 25: 414-418.
24. Al-Mayouf SM, Al Sonbul A. Influence of gender and age of onset on the outcome in children with systemic lupus erythematosus. Clin Rheumatol 2008 ; 27: 1159-1162.
25. Thumboo J., Feng PH, Soh CH, Boey ML, Thio S., Fong KY Validation of a Chinese version of the Medical Outcomes Study Family and Marital Functioning Measures in patients with SLE. Lupus 2000 ; 9: 702-707.
26. Rabbani MA, Habib HB, Islam M., et al. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients. Lupus 2009 ; 18: 848-855.
27. Mok CC, Ho CT, Wong RW, Lau CS Damage accrual in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2003 ; 30: 1513-1519.
28. Sung YK, Hur NW, Sinskey JL, Park D., Bae SC Assessment of damage in Korean patients with systemic lupus erythematosus. J Rheumatol 2007 ; 34: 987-991.
29. Molad Y., Gorshtein A., Wysenbeek AJ, et al. Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort. Lupus 2002 ; 11: 356-361.
30. Durán S., Apte M., Alarcón GS LUMINA Study Group. Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups. J Natl Med Assoc 2007 ; 99: 1196-1198.
31. Cooper GS, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus. Arthritis Rheum 2007 ; 57: 993-999.
32. Ye DQ, Yang SG, Li XP, et al. Polymorphisms in the promoter region of RANTES in Han Chinese and their relationship with systemic lupus erythematosus. Arch Dermatol Res 2005 ; 297: 108-113.
33. Boumpas DT, Austin III HA, Vaughan EM, Yarboro CH, Klippel JH, Barlow JE Risk of sustained amenorrhoea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 1993 ; 119: 366-369.
34. Guarize J., Appenzeller S., Costallat LT Skin damage occurs early in systemic lupus erythematosus and independently of disease duration in Brazilian patients. Rheumatol Int 2007 ; 27: 483-487.
35. Vilar MJP, Bezerra ELM, Sato EI Skin is the most frequently damaged system in recent-onset systemic lupus erythematosus in a tropical region. Clin Rheumatol 2005 ; 24: 377-380.
36. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976 ; 60: 221-225.
37. Cervera R., Font J., Shoenfeld Y. European working party on systemic lupus erythematosus: a 15-year report. Autoimmun Rev 2006 ; 5: 549-553.
38. Boey ML, Peebles CL, Tsay G., et al. Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis 1988 ; 47 ; 11: 918-923.
39. Lee SS, Li CS, Li PC Clinical profile of Chinese patients with systemic lupus erythematosus. Lupus 1993 ; 2: 105-109.
40. Shayakul C., Ong-aj-yooth L., Chirawong P., et al. Lupus nephritis in Thailand: clinicopathologic findings and outcome in 569 patients. Am J Kidney Dis 1995 ; 26: 300-307.
41. Williams W., Bhagwandass A., Sargeant LA, Shah D. Severity of systemic lupus erythematosus with diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse intravenous cyclophosphamide therapy in Jamaican patients. Lupus 2003 ; 12: 640-645.
42. Maddison P., Farewell V., Isenberg D., et al. The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol 2002 ; 29: 913-917.
43. Nossent JC SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis. J Rheumatol 1998 ; 25: 654-659.
44. Barr SG, Zonana-Nacach A., Magder LS, Petri M. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum 1999 ; 42: 2682-2688.
45. Brunner HI, Silverman ED, To T., Bombardier C., Feldman BM Risk factors for damage in childhood-onset systemic lupus erythematosus: Cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002 ; 46: 436-444.
46. Ravelli A., Duarte-Salazar C., Buratti S., et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 2003 ; 49: 501-507.
47. Rahman P., Gladman DD, Urowitz MB, Hallett D., Tam LS Corticosteroid induced morbidity in SLE. Arthritis Rheum 1999 ; 42: S96.